Jung‐Hui Sun

1.0k total citations
12 papers, 664 citations indexed

About

Jung‐Hui Sun is a scholar working on Organic Chemistry, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Jung‐Hui Sun has authored 12 papers receiving a total of 664 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Organic Chemistry, 5 papers in Molecular Biology and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Jung‐Hui Sun's work include Cancer therapeutics and mechanisms (2 papers), Chemical Synthesis and Analysis (2 papers) and Synthesis and Reactivity of Heterocycles (2 papers). Jung‐Hui Sun is often cited by papers focused on Cancer therapeutics and mechanisms (2 papers), Chemical Synthesis and Analysis (2 papers) and Synthesis and Reactivity of Heterocycles (2 papers). Jung‐Hui Sun collaborates with scholars based in United States. Jung‐Hui Sun's co-authors include Christopher A. Teleha, David A. Nugiel, James D. Rodgers, Ilgar Abbaszade, Lawrence W. Fitzgerald, David W. Robertson, Paul C. Meunier, John P. Patterson, Albert J. Robichaud and Paul Hartig and has published in prestigious journals such as Journal of Medicinal Chemistry, The Journal of Organic Chemistry and Molecular Pharmacology.

In The Last Decade

Jung‐Hui Sun

11 papers receiving 640 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jung‐Hui Sun United States 7 263 199 149 144 92 12 664
M. Ohno Japan 14 224 0.9× 411 2.1× 74 0.5× 71 0.5× 85 0.9× 34 734
Pedro Besada Spain 20 388 1.5× 439 2.2× 76 0.5× 95 0.7× 61 0.7× 50 964
Christopher S. Konkoy United States 16 170 0.6× 386 1.9× 260 1.7× 67 0.5× 133 1.4× 23 888
Grant Wishart United Kingdom 13 218 0.8× 397 2.0× 103 0.7× 80 0.6× 56 0.6× 29 633
Rebecca B. White United States 14 181 0.7× 198 1.0× 55 0.4× 81 0.6× 42 0.5× 27 636
Petra Arndt Germany 13 55 0.2× 382 1.9× 191 1.3× 138 1.0× 25 0.3× 17 1.4k
Hartmut E. Greiner Germany 17 234 0.9× 394 2.0× 314 2.1× 100 0.7× 17 0.2× 32 839
Marcus F. Brackeen United States 12 202 0.8× 253 1.3× 78 0.5× 87 0.6× 38 0.4× 16 651
Katsuichi Shuto Japan 12 128 0.5× 246 1.2× 100 0.7× 78 0.5× 52 0.6× 88 639
Anthony H. Ingall United Kingdom 12 170 0.6× 240 1.2× 74 0.5× 44 0.3× 173 1.9× 14 789

Countries citing papers authored by Jung‐Hui Sun

Since Specialization
Citations

This map shows the geographic impact of Jung‐Hui Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jung‐Hui Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jung‐Hui Sun more than expected).

Fields of papers citing papers by Jung‐Hui Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jung‐Hui Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jung‐Hui Sun. The network helps show where Jung‐Hui Sun may publish in the future.

Co-authorship network of co-authors of Jung‐Hui Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Jung‐Hui Sun. A scholar is included among the top collaborators of Jung‐Hui Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jung‐Hui Sun. Jung‐Hui Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Zhao, Rui-Lin, Bei Wang, Michael Wong, et al.. (2024). Evolution of the Synthetic Process to an Advanced GPR40 Agonist. Organic Process Research & Development. 28(1). 310–324. 3 indexed citations
3.
Wityak, John, Frank W. Hobbs, Daniel S. Gardner, et al.. (2004). Beyond U0126. Dianion chemistry leading to the rapid synthesis of a series of potent MEK inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(6). 1483–1486. 24 indexed citations
4.
Sun, Jung‐Hui, et al.. (2004). Synthesis of N-Butyl Side Chain Hydroxylated Metabolites of Roxifiban, a Platelet Glycoprotein IIb/IIIa Receptor Antagonist. Heterocycles. 63(7). 1585–1585. 1 indexed citations
5.
Fitzgerald, Lawrence W., Timothy C. Burn, Barry S. Brown, et al.. (2000). Possible Role of Valvular Serotonin 5-HT2B Receptors in the Cardiopathy Associated with Fenfluramine. Molecular Pharmacology. 57(1). 75–81. 343 indexed citations
6.
Sun, Jung‐Hui, et al.. (1999). Synthesis of Losoxantrone Metabolites Isolated from Human Urine. Heterocycles. 51(11). 2603–2603.
7.
Sun, Jung‐Hui, et al.. (1998). An Efficient Synthesis of 2-(((9-Fluorenylmethoxycarbonyl)amino)methyl)benzoic Acid. Synthetic Communications. 28(24). 4525–4530. 2 indexed citations
8.
Cherney, Robert J., Jung‐Hui Sun, Robert F. Kaltenbach, et al.. (1997). The synthesis and antitumor evaluation of unsymmetrical bis-imides. Bioorganic & Medicinal Chemistry Letters. 7(2). 163–168. 8 indexed citations
9.
Sun, Jung‐Hui, et al.. (1997). Efficient Synthesis of 5-(Bromomethyl)- and 5-(Aminomethyl)-1-THP-Indazole. The Journal of Organic Chemistry. 62(16). 5627–5629. 113 indexed citations
10.
Houghton, Peter J., Pamela J. Cheshire, Janet L. Gross, et al.. (1994). Evaluation of a novel bis-naphthalimide anticancer agent, DMP 840, against human xenografts derived from adult, juvenile, and pediatric cancers. Cancer Chemotherapy and Pharmacology. 33(4). 265–272. 1 indexed citations
11.
Taylor, Edward C. & Jung‐Hui Sun. (1980). A New Synthesis of Aminomalononitrile Tosylate. Synthesis. 1980(10). 801–802. 16 indexed citations
12.
Schneller, Stewart W. & Jung‐Hui Sun. (1977). The Reaction of 1,2-Diamines with a 2,3-Dioxopyrrolidines as an Approach to Pyrrolo[2,3-b]pyrazines. Heterocycles. 6(2). 137–137. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026